HEAD OF CLINICAL DEVELOPMENTSong Kim, MD

Dr. Song Kim has over a decade of experience in clinical development across several therapeutic areas and regions. She joins Karis Bio Inc. as a head of clinical development from Hanmi Pharmaceuticals, where she led early-stage clinical trials targeting novel therapies. Prior to Hanmi Pharmaceuticals, she served as a regional medical expert at Novartis AG and medical director at Novartis Korea leading medical programs. She also worked at McKinsey & Company, supported companies to develop an innovation strategy in Pharmaceutical sector. As a clinician by training, she earned an MD from Yonsei University and trained in dermatology at Samsung Medical Center, Korea.

song.kim@karisbio.com

ADVANCED-DEGREE SCIENTISTSOur Team

https://i0.wp.com/karisbio.com/wp-content/uploads/2021/05/Team_SJLee-1.jpg?fit=380%2C430&ssl=1

CHIEF TECNOLOGY OFFICERShin-Jeong Lee, PhD

https://i0.wp.com/karisbio.com/wp-content/uploads/2021/05/Team_SKim-1.jpg?fit=380%2C430&ssl=1

HEAD OF CLINICAL DEVELOPMENTSong Kim, MD

https://i0.wp.com/karisbio.com/wp-content/uploads/2021/05/Team_SSKim-1.jpg?fit=380%2C430&ssl=1

R&D DIRECTORSangsung Kim, MS